Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 - 2014)

Renub Research
September 20, 2010
89 Pages - SKU: RNBR2817065
License type:
Countries covered: Global

Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 - 2014)

 
Our new report “Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 - 2014)” examines the commercial prospects for In Vitro Diagnostics (IVD) in the global healthcare market. The report provides market landscape, competitive landscape and market trends information on ten market categories including Molecular Diagnostics, Clinical Chemistry, Hematology, Immunoassay, Point of Care Testing, Microbiology, Histology/Cytology, Flow Cytometry, Blood Screening Typing, and Coagulation. The report provides comprehensive information on the key trends affecting these categories, and key analytical insight on the market dynamics. The report reviews the competitive landscape in terms of mergers and acquisitions, licensing, pipeline products and new technology offerings. The report also analyses past present and future forecast of USA, Japan, Europe, India, China and Taiwan IVD market.

The report has been researched at source globally and features latest available data covering:
  • Ten IVD sub-segment past, present and future forecast market share
  • Six countries (USA, Japan, Europe, India, China, Taiwan) past, present, future prospects in the IVD market
  • Top eight companies (Sysmex, BioMerieux, OCD (J&J), Beckman Coulter, BD, Abbott Diagnostics, Siemens & Roche) IVD market share in 2009
  • Top ten Merger & Acquisition deals in 2008 and 2009
  • Licensing by ten IVD players
  • Review of International In Vitro Diagnostics Regulations
  • Key drivers of growth in the global IVD market
  • Key challenges faces by IVD market in the coming years
Research Highlights
  • Globally, In Vitro Diagnostics market will cross US$ 60 Billion by 2014
  • Point of Care Testing dominates the In Vitro Diagnostics market with more than 30% market share in 2009
  • Molecular Diagnostics is the fastest growing segment in the In Vitro Diagnostics market, its market share will reach approximately 18% by 2014
  • In 2009 Roche, Siemens and Abbott Diagnostics together controls 42% market share in In Vitro Diagnostics, Roche controls the highest market share
  • After Point of Care Testing, Immunoassay is the second largest market with a market of more than US$ 7 Billion in 2009
  • Europe with more than US$ 10 Billion is the second largest In Vitro Diagnostics Market in 2009
  • 51 Mergers & Acquisitions taken place in 2008 compared to 84 deals in 2007
  • 18 In-Licensing deals were announced in 2008 compared to 27 in 2007
  • By 2009 there were 12 countries with more than 10 Million people aged 60 or over
  • Third Wave Technologies (TWT) was acquired by Hologic to grow its existing women’s health and diagnostics business was the best deal in 2008
  • In 2009, Beckman Coulter acquired the diagnostic systems part of Olympus’s life sciences to broaden its clinical chemistry offering, especially in the ultra-high throughput setting.
Key Players Analyzed

This section covers the key facts about the major players in In Vitro Diagnostics market. The key players analyzed in this section are - Roche, Sysmex, Biomerieux, OCD(J&J), Beckman Coulter, BD, Abbott Diagnostics, Siemens.

Data Sources

Information and data in this report has been collected from various printable and non-printable sources like Trade Journals, White papers, Online paid databases, News websites, Government Agencies, Magazines, Newspapers and Trade associations.


More Global Molecular Diagnostics Reports

In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers & Microbiology Culture) – Global Trends & Forecasts to 2016 by MarketsandMarkets
The global in-vitro diagnostics (IVD) market was valued at $44 billion in 2011 and is expected to have a modest growth during the study period. ...

2012 World Molecular Diagnostics Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country by Venture Planning Group
This report provides a worldwide overview of the molecular diagnostics market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as ...

2012 Global Molecular Diagnostics Market Outlook: Growth Opportunities and Strategies by Venture Planning Group
The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next ten years will witness significant ...

The 2012 Global Molecular Diagnostics Market: Facilities, Test Volumes, and Sales Forecasts by Country by Venture Planning Group
This report provides a worldwide overview of the molecular diagnostics market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as ...

Genetic Testing by Global Industry Analysts
This report analyzes the worldwide markets for Genetic Testing in US$ Million. The US market is analyzed by the following Segments: Prenatal and Newborn Genetic ...

See all reports like this >>